SERCA1a can structurally and functionally substitute for SERCA2a in the heart, providing a potential mechanism to enhance SR Ca2+ transport and cardiac contractility.
No takes yet. Share an insight, caveat, or question.
Does not support clinical use; leaves open SERCA1a as a therapeutic target pending human studies.
Lalli et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: